“The flat world will challenge cherished beliefs,” said Frank Douglas, Executive Director of the newly formed MIT Center for Biomedical Innovation. In this podcast, you’ll hear Douglas’ keynote speech on the challenges and opportunities for biopharmacology in a flat world at TiECON East in Boston. Until his recent retirement from industry, Dr. Douglas was Executive Vice President, Drug Innovation and Approval, and Chief Scientific Officer of Aventis SA, where he oversaw global pharmaceutical research, development and regulatory activities.
More info at:
TieCONEast.org
See also:
TiEcon 2006 Podcasts
Tags: Frank Douglas, MIT, Biomedical, TiECON, Aventis
Press:
pr@podtech.net
Sales:
sales@podtech.net
Feedback:
feedback@podtech.net
PodTech Network is committed to protecting your online privacy while providing you with the most useful and enjoyable Web experience possible.
Copyright ©2008 PodTech.net. All rights reserved. Modified: Thu, 24 May 2012 17:31:30 -0700
#